Expansion. The pharmaceutical industry faces the double challenge of incorporating innovation into a budget-strapped healthcare system while working to ensure its sustainability. Thus, "accelerating access to innovative treatments is essential, but for this it is necessary to identify why new medicines, once evaluated, are not incorporated into the market," said Belén Crespo, director of the Spanish Agency for Medicines and Health Products ( AEMPS), during the opening of the Innovation and Sustainability in the Pharmaceutical Industry Meeting, organized by Unidad Editorial Events and Conferences and sponsored by Sandoz, Almirall and Roche, with the collaboration of EXPANSIÓN, Correo Farmacéutico and Diario Médico.